$1.7799
0.0599[3.48%]
At close: Apr 23
$1.7799
0[0.00%]
After Hours: 5:40PM EDT
Equillium
(NASDAQ:EQ)Latest News for Equillium Stock (NASDAQ:EQ)
Equillium Stock (NASDAQ: EQ)
Categories: All
Tuesday, April 02, 2024
Tuesday, March 26, 2024
- Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Mar 26, 2024, 1:45PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Mar 26, 2024, 1:31PM
- Equillium shares are trading lower. The company reported Q4 financial results.Benzinga Newsdesk - Mar 26, 2024, 12:11PM
Monday, March 25, 2024
Monday, February 19, 2024
Friday, February 16, 2024
Tuesday, February 06, 2024
Tuesday, December 26, 2023
Thursday, December 21, 2023
Monday, November 13, 2023
Wednesday, November 08, 2023
Monday, November 06, 2023
Monday, October 16, 2023
Monday, August 14, 2023
Wednesday, August 09, 2023
Thursday, August 03, 2023
Wednesday, August 02, 2023
Wednesday, May 24, 2023
- Equillium Board Member Awarded $13K Worth of Stock OptionsBenzinga Insights - May 24, 2023, 11:02AM
- Director at Equillium Acquires Company Stock Options Worth 20,000 SharesBenzinga Insights - May 24, 2023, 11:02AM
- Board Member at Equillium Acquires Company Stock Options Worth 20,000 SharesBenzinga Insights - May 24, 2023, 11:02AM
- Equillium Director Awarded $13K Worth of Stock OptionsBenzinga Insights - May 24, 2023, 11:01AM
Monday, May 15, 2023
Monday, May 01, 2023
Friday, March 24, 2023
Thursday, March 23, 2023
Friday, March 10, 2023
Monday, February 20, 2023
Thursday, February 09, 2023
Wednesday, February 08, 2023
Tuesday, December 27, 2022
Friday, December 23, 2022
Friday, December 16, 2022
Monday, December 12, 2022
Wednesday, December 07, 2022
Tuesday, December 06, 2022
- Autoimmune Biotech Scores $26M Payment, Up To $139M To Advance Phase 3 ResearchVandana Singh - Dec 6, 2022, 12:17PM
- Equillium And Ono Pharmaceutical Announce Exclusive Option And Asset Purchase Agreement For Development And Commercialization Of Itolizumab; Equillium To Receive $26.0M Upfront Payment And Up To $138.5M In Option Exercise And Milestone PaymentsBill Haddad - Dec 6, 2022, 7:02AM